FDA Approves New Tolerances for Apramycin in Swine

Summary

The US Food and Drug Administration (FDA) has amended animal drug regulations to reflect approval of two supplemental new animal drug applications (NADA's) filed by Elanco Animal Health, a division of Eli Lilly & Co., which provide revised tolerances for total residues of apramycin in edible swine tissues.